The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients (pts) with advanced HER2+ (IHC3+) gastric carcinoma (GC).
 
Daniel V.T. Catenacci
Honoraria - Amgen; Bristol-Myers Squibb; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; Genmab; Gritstone Bio; Guardant Health; Lilly; Merck; NantWorks; OncoPlex Diagnostics; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Astellas Pharma; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; Taiho Pharmaceutical
Speakers' Bureau - Foundation Medicine; Guardant Health
 
Kian Huat Lim
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Gilead Sciences (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Regeneron (Inst); Roche (Inst); Taiho Pharmaceutical (Inst); Vertex (Inst); Vertex (Inst)
 
Hope Elizabeth Uronis
Employment - GeneCentric (I)
Stock and Other Ownership Interests - GeneCentric (I)
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Advaxis (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lycera (Inst); Macrogenics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Yoon-Koo Kang
Consulting or Advisory Role - Bristol-Myers Squibb; DAEHWA Pharmaceutical; Lilly/ImClone; Merck Serono; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - DAEHWA Pharmaceutical; LSK Biopharma
 
Matthew C.H. Ng
Honoraria - MSD Oncology; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; MSD Oncology
Research Funding - ASLAN Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Taiho Pharmaceutical
 
Philip Jordan Gold
No Relationships to Disclose
 
Peter C. Enzinger
Consulting or Advisory Role - Astellas Pharma; Five Prime Therapeutics; Merck; Taiho Pharmaceutical
 
Keun Wook Lee
Research Funding - Array BioPharma (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Five Prime Therapeutics (Inst); Green Cross (Inst); LSK BioPharma (Inst); Macrogenics (Inst); Merck KGaA (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Pharmacyclics (Inst)
 
Jill Lacy
Consulting or Advisory Role - AstraZeneca; Celgene; KeyQuest Health; Navigant Consulting; Sirtex Medical
Travel, Accommodations, Expenses - Lilly
 
Se Hoon Park
Consulting or Advisory Role - Lilly
 
Jennifer Yen
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Justin Odegaard
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Aleksandra Franovic
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Jan E. Baughman
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Aisha Wynter-Horton
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Francine Chen
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
Patents, Royalties, Other Intellectual Property - Patent Award/Application: 1. Antibodies Reactive with B7H3 immunological activity fragments thereof and Uses Thereof 2. Bi-Specific Monovalent Diabodies That Are Capable Of Binding to GPA33 And CD3, And Uses Thereof (Inst)
 
Paul A. Moore
Stock and Other Ownership Interests - GlaxoSmithKline; Medtronic; Teva
Patents, Royalties, Other Intellectual Property - Have patents based on work at MacroGenics, Human Genome Sciences and Celera
 
Tony Wu
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Jan Kenneth Davidson-Moncada
Employment - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Yung-Jue Bang
Consulting or Advisory Role - AstraZeneca/MedImmune; Bayer; BeiGene; Green Cross; Hanmi; Merck Serono; MSD Oncology; Novartis; Samyang; Taiho Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Chong Kun Dang Pharmaceutical (Inst); Curis (Inst); Daiichi Sankyo (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Green Cross (Inst); Lilly (Inst); Macrogenics (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)